Abstract
Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: The V-HEALTH study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have